101
Views
255
CrossRef citations to date
0
Altmetric
Cell Growth and Development

FRS2 Proteins Recruit Intracellular Signaling Pathways by Binding to Diverse Targets on Fibroblast Growth Factor and Nerve Growth Factor Receptors

, , , , , & show all
Pages 979-989 | Received 14 May 1999, Accepted 29 Oct 1999, Published online: 28 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (15)

Sneha Bharti & Harini Chowdary Vadlamudi. (2021) A strategic review on the involvement of receptors, transcription factors and hormones in acne pathogenesis. Journal of Receptors and Signal Transduction 41:2, pages 105-116.
Read now
Dan Wang, Li Yang, Weina Yu & Yi Zhang. (2019) Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors. Expert Opinion on Investigational Drugs 28:10, pages 903-916.
Read now
Clarisse R Mazzola, Khurram M Siddiqui, Michele Billia & Joseph Chin. (2014) Dovitinib: rationale, preclinical and early clinical data in urothelial carcinoma of the bladder. Expert Opinion on Investigational Drugs 23:11, pages 1553-1562.
Read now
Agnes Csiszar, Elisabeth Vogelsang, Hartmut Beug & Maria Leptin. (2010) A Novel Conserved Phosphotyrosine Motif in the Drosophila Fibroblast Growth Factor Signaling Adaptor Dof with a Redundant Role in Signal Transmission. Molecular and Cellular Biology 30:8, pages 2017-2027.
Read now
Takuya Sato & Noriko Gotoh. (2009) The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment. Expert Opinion on Therapeutic Targets 13:6, pages 689-700.
Read now
Bodo Melnik. (2009) Role of FGFR2-signaling in the pathogenesis of acne. Dermato-Endocrinology 1:3, pages 141-156.
Read now
N. Gotoh, K. Manova, S. Tanaka, M. Murohashi, Y. Hadari, A. Lee, Y. Hamada, T. Hiroe, M. Ito, T. Kurihara, H. Nakazato, M. Shibuya, I. Lax, E. Lacy & J. Schlessinger. (2005) The Docking Protein FRS2α Is an Essential Component of Multiple Fibroblast Growth Factor Responses during Early Mouse Development. Molecular and Cellular Biology 25:10, pages 4105-4116.
Read now
Valérie Petit, Ute Nussbaumer, Caroline Dossenbach & Markus Affolter. (2004) Downstream-of-FGFR Is a Fibroblast Growth Factor-Specific Scaffolding Protein and Recruits Corkscrew upon Receptor Activation. Molecular and Cellular Biology 24:9, pages 3769-3781.
Read now
Robert Wilson, Alysia Battersby, Agnes Csiszar, Elisabeth Vogelsang & Maria Leptin. (2004) A Functional Domain of Dof That Is Required for Fibroblast Growth Factor Signaling. Molecular and Cellular Biology 24:6, pages 2263-2276.
Read now
Yehenew M. Agazie & Michael J. Hayman. (2003) Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling. Molecular and Cellular Biology 23:21, pages 7875-7886.
Read now
Nina Jones, Stephen H. Chen, Celina Sturk, Zubin Master, Jennifer Tran, Robert S. Kerbel & Daniel J. Dumont. (2003) A Unique Autophosphorylation Site on Tie2/Tek Mediates Dok-R Phosphotyrosine Binding Domain Binding and Function. Molecular and Cellular Biology 23:8, pages 2658-2668.
Read now
Maria I. Kontaridis, Xiangdong Liu, Lei Zhang & Anton M. Bennett. (2002) Role of SHP-2 in Fibroblast Growth Factor Receptor-Mediated Suppression of Myogenesis in C2C12 Myoblasts. Molecular and Cellular Biology 22:11, pages 3875-3891.
Read now
Eui Kyun Park, Neil Warner, Kathleen Mood, Tony Pawson & Ira O. Daar. (2002) Low-Molecular-Weight Protein Tyrosine Phosphatase Is a Positive Component of the Fibroblast Growth Factor Receptor Signaling Pathway. Molecular and Cellular Biology 22:10, pages 3404-3414.
Read now
R. M. Melillo, M. Santoro, S.-H. Ong, M. Billaud, A. Fusco, Y. R. Hadari, J. Schlessinger & I. Lax. (2001) Docking Protein FRS2 Links the Protein Tyrosine Kinase RET and Its Oncogenic Forms with the Mitogen-Activated Protein Kinase Signaling Cascade. Molecular and Cellular Biology 21:13, pages 4177-4187.
Read now

Articles from other publishers (240)

Adarsh Kumar, Kuber Kumar Bhagat, Ankit Kumar Singh, Harshwardhan Singh, Tanuja Angre, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid Emwas & Pradeep Kumar. (2023) Medicinal chemistry perspective of pyrido[2,3- d ]pyrimidines as anticancer agents . RSC Advances 13:10, pages 6872-6908.
Crossref
Yanrong Long, Hongbin Chen, Junchao Deng, Junjie Ning, Pengbo Yang, Lina Qiao & Zhongwei Cao. (2022) Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice. Frontiers in Pharmacology 13.
Crossref
Quanquan Lin, Zhanjie Fang, Jinlong Sun, Fei Chen, Yipeng Ren, Zhenhong Fu, Sefei Yang, Lin Feng, Feng Wang, Zhigang Song, Wei Chen, Wenjun Yu, Chen Wang, Yixin Shi, Yue Liang, Haizhong Zhang, Hongzhu Qu, Xiangdong Fang & Qing Xi. (2022) Single-cell transcriptomic analysis of the tumor ecosystem of adenoid cystic carcinoma. Frontiers in Oncology 12.
Crossref
Aditya V. Shreenivas, Shumei Kato, Jingjing Hu, Catherine Skefos, Jason Sicklick & Razelle Kurzrock. (2022) Carcinoma of unknown primary: Molecular tumor board‐based therapy. CA: A Cancer Journal for Clinicians 72:6, pages 510-523.
Crossref
Le Guo, Jin Liu, Xueqing Nie, Taobo Wang, Zhi-xiong Ma, Dan Yin & Weiping Tang. (2022) Development of selective FGFR1 degraders using a Rapid synthesis of proteolysis targeting Chimera (Rapid-TAC) platform. Bioorganic & Medicinal Chemistry Letters 75, pages 128982.
Crossref
Peter Ellinghaus, Daniel Neureiter, Hendrik Nogai, Sebastian Stintzing & Matthias Ocker. (2022) Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?. Cells 11:19, pages 3180.
Crossref
Zhihong Liu, Zhichen Liu, Qing Mu, Meng Zhao, Ting Cai, Yuchun Xie, Cun Zhao, Qing Qin, Chongyan Zhang, Xiaolong Xu, Mingxi Lan, Yanjun Zhang, Rui Su, Zhiying Wang, Ruijun Wang, Zhixin Wang, Jinquan Li & Yanhong Zhao. (2022) Identification of key pathways and genes that regulate cashmere development in cashmere goats mediated by exogenous melatonin. Frontiers in Veterinary Science 9.
Crossref
Katarzyna Bzdega & Justyna A. Karolak. (2022) Phenotypic spectrum of FGF10 -related disorders: a systematic review . PeerJ 10, pages e14003.
Crossref
Xiaolong Zhu, Cong Qiu, Yiran Wang, Yuanqing Jiang, Yefeng Chen, Linge Fan, Ruizhe Ren, Yunyun Wang, Yu Chen, Yanzhi Feng, Xiaofei Zhou, Yunhui Zhu, Zhen Ge, Dongwu Lai, Lingfeng Qin, Michael Simons & Luyang Yu. (2022) FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis. Proceedings of the National Academy of Sciences 119:26.
Crossref
Emanuel Gasser, Gencer Sancar, Michael Downes & Ronald M. Evans. (2022) Metabolic Messengers: fibroblast growth factor 1. Nature Metabolism 4:6, pages 663-671.
Crossref
Jia Zheng, Wei Zhang, Linfeng Li, Yi He, Yue Wei, Yongjun Dang, Shenyou Nie & Zufeng Guo. (2022) Signaling Pathway and Small-Molecule Drug Discovery of FGFR: A Comprehensive Review. Frontiers in Chemistry 10.
Crossref
Chi-Chuan Lin, Kin Man Suen, Polly-Anne Jeffrey, Lukasz Wieteska, Jessica A. Lidster, Peng Bao, Alistair P. Curd, Amy Stainthorp, Caroline Seiler, Hans Koss, Eric Miska, Zamal Ahmed, Stephen D. Evans, Carmen Molina-París & John E. Ladbury. (2022) Receptor tyrosine kinases regulate signal transduction through a liquid-liquid phase separated state. Molecular Cell 82:6, pages 1089-1106.e12.
Crossref
Chiara Francavilla & Ciara S. O'Brien. (2022) Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer. Open Biology 12:2.
Crossref
Csongor G. Lengyel, Sadaqat Hussain, Andreas Seeber, Sara Jamil Nidhamalddin, Dario Trapani, Baker S. Habeeb, Essam Elfaham, Syed Ayub Mazher, Fahmi Seid, Shah Z. Khan, Khalid El Bairi, Andrew Odhiambo, Sara C. Altuna & Angelica Petrillo. (2022) FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?. Life 12:1, pages 81.
Crossref
Lingfeng Chen, Yanmei Zhang, Lina Yin, Binhao Cai, Ping Huang, Xiaokun Li & Guang Liang. (2021) Fibroblast growth factor receptor fusions in cancer: opportunities and challenges. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Akhil Padarti, Johnathan Abou-Fadel & Jun Zhang. (2021) Resurgence of phosphotyrosine binding domains: Structural and functional properties essential for understanding disease pathogenesis. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:11, pages 129977.
Crossref
Lars Klimaschewski & Peter Claus. (2021) Fibroblast Growth Factor Signalling in the Diseased Nervous System. Molecular Neurobiology 58:8, pages 3884-3902.
Crossref
Michael J. Bond & Craig M. Crews. (2021) Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation. RSC Chemical Biology 2:3, pages 725-742.
Crossref
Harriet R. Ferguson, Michael P. Smith & Chiara Francavilla. (2021) Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling. Cells 10:5, pages 1201.
Crossref
Richard J. Epstein, Li Jun Tian & Yan Fei Gu. (2021) 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology. Journal of Oncology 2021, pages 1-16.
Crossref
Vanessa Y. C. Sung, Jennifer F. Knight, Radia M. Johnson, Yaakov E. Stern, Sadiq M. Saleh, Paul Savage, Anie Monast, Dongmei Zuo, Stéphanie Duhamel & Morag Park. (2021) Co-dependency for MET and FGFR1 in basal triple-negative breast cancers. npj Breast Cancer 7:1.
Crossref
Youssef Abdalla, Meihua Luo, Ermei Mäkilä, Bryan W. Day, Nicolas H. Voelcker & Wing Yin Tong. (2021) Effectiveness of porous silicon nanoparticle treatment at inhibiting the migration of a heterogeneous glioma cell population. Journal of Nanobiotechnology 19:1.
Crossref
Marta Grońska-Pęski, Wenzhu Mowrey & Jean M. Hébert. (2021) FGFR Regulation of Dendrite Elaboration in Adult-born Granule Cells Depends on Intracellular Mediator and Proximity to the Soma. Neuroscience 453, pages 148-167.
Crossref
Alexandru Tirpe, Diana Gulei, George Razvan Tirpe, Andreea Nutu, Alexandru Irimie, Paola Campomenosi, Laura Ancuta Pop & Ioana Berindan-Neagoe. (2020) Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy. International Journal of Molecular Sciences 21:21, pages 8002.
Crossref
Yangli Xie, Allen Zinkle, Lin Chen & Moosa Mohammadi. (2020) Fibroblast growth factor signalling in osteoarthritis and cartilage repair. Nature Reviews Rheumatology 16:10, pages 547-564.
Crossref
Dongying Chen, Xiaolong Zhu, Natalie Kofler, Yidong Wang, Bin Zhou & Michael Simons. (2020) FRS2α-dependent cell fate transition during endocardial cushion morphogenesis. Developmental Biology 458:1, pages 88-97.
Crossref
Isaac Angert, Siddarth Reddy Karuka, Jared Hennen, Yan Chen, Joseph P. Albanesi, Louis M. Mansky & Joachim D. Mueller. (2020) Sensitive Detection of Protein Binding to the Plasma Membrane with Dual-Color Z-Scan Fluorescence. Biophysical Journal 118:2, pages 281-293.
Crossref
Sophia Karouzaki, Charoula Peta, Emmanouella Tsirimonaki & Dimitra Mangoura. (2019) PKCε-dependent H-Ras activation encompasses the recruitment of the RasGEF SOS1 and of the RasGAP neurofibromin in the lipid rafts of embryonic neurons. Neurochemistry International 131, pages 104582.
Crossref
Michael Notaras & Maarten van den Buuse. (2018) Brain-Derived Neurotrophic Factor (BDNF): Novel Insights into Regulation and Genetic Variation. The Neuroscientist 25:5, pages 434-454.
Crossref
Rajeswari Appadurai, Vladimir N. Uversky & Anand Srivastava. (2019) The Structural and Functional Diversity of Intrinsically Disordered Regions in Transmembrane Proteins. The Journal of Membrane Biology 252:4-5, pages 273-292.
Crossref
Barbara Barylko, Yu-Ju Chen, Jared Hennen, Isaac Angert, Yan Chen, Joachim D. Mueller, Hui-Qiao Sun, Clinton A. TaylorIVIV, Jen Liou, Helen Yin & Joseph P. Albanesi. (2019) Myristoylation-Dependent Palmitoylation of the Receptor Tyrosine Kinase Adaptor FRS2α. Biochemistry 58:25, pages 2809-2813.
Crossref
Malgorzata Zakrzewska, Lukasz Opalinski, Ellen M. Haugsten, Jacek Otlewski & Antoni Wiedlocha. (2019) Crosstalk between p38 and Erk 1/2 in Downregulation of FGF1-Induced Signaling. International Journal of Molecular Sciences 20:8, pages 1826.
Crossref
Michaela Kunova Bosakova, Alexandru NitaTomas GregorMiroslav VarechaIva GudernovaBohumil FafilekTomas BartaNeha BasheerSara P. AbrahamLukas BalekMarketa TomanovaJana Fialova KucerovaJuraj BosakDavid PotesilJennifer ZiebaJieun SongPeter Konik, Sohyun ParkIvan Duran, Zbynek ZdrahalDavid SmajsGert Jansen, Zheng FuHyuk Wan Ko, Ales HamplLukas TrantirekDeborah Krakow & Pavel Krejci. (2019) Fibroblast growth factor receptor influences primary cilium length through an interaction with intestinal cell kinase. Proceedings of the National Academy of Sciences 116:10, pages 4316-4325.
Crossref
Molly R. Ryan, Christal D. Sohl, BeiBei Luo & Karen S. Anderson. (2019) The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT. Molecular Cancer Research 17:2, pages 532-543.
Crossref
Agata Kurowski, Andrei Molotkov & Philippe Soriano. (2019) FGFR1 regulates trophectoderm development and facilitates blastocyst implantation. Developmental Biology 446:1, pages 94-101.
Crossref
Tim H. Holmström, Anu-Maarit Moilanen, Tarja Ikonen, Mari L. Björkman, Tero Linnanen, Gerd Wohlfahrt, Stefan Karlsson, Riikka Oksala, Timo Korjamo, Susanta Samajdar, Srinivasan Rajagopalan, Shekar Chelur, Kishore Narayanan, Raghuveer K. Ramachandra, Jiju Mani, Rashmi Nair, Nagaraj Gowda, Thomas Anthony, Samiulla Dhodheri, Subhendu Mukherjee, Ravi K. Ujjinamatada, Nanduri Srinivas, Murali Ramachandra & Pekka J. Kallio. (2019) ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity. Molecular Cancer Therapeutics 18:1, pages 28-38.
Crossref
Natalia Porębska, Marta Latko, Marika Kucińska, Małgorzata Zakrzewska, Jacek Otlewski & Łukasz Opaliński. (2018) Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment. Journal of Clinical Medicine 8:1, pages 7.
Crossref
Joanne Watson & Chiara Francavilla. (2018) Regulation of FGF10 Signaling in Development and Disease. Frontiers in Genetics 9.
Crossref
Ramesh Singh, Dileep Karri, Hong Shen, Jiangyong Shao, Subhamoy Dasgupta, Shixia Huang, Dean P. Edwards, Michael M. Ittmann, Bert W. O’Malley & Ping Yi. (2018) TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis. Journal of Clinical Investigation 128:7, pages 3129-3143.
Crossref
Eugene.L. Boshoff, Edward.J.R. Fletcher & Susan Duty. (2018) Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner. Neuropharmacology 137, pages 156-163.
Crossref
Kevin G. Coleman & Craig M. Crews. (2018) Proteolysis-Targeting Chimeras: Harnessing the Ubiquitin-Proteasome System to Induce Degradation of Specific Target Proteins. Annual Review of Cancer Biology 2:1, pages 41-58.
Crossref
Allen Zinkle & Moosa Mohammadi. (2018) A threshold model for receptor tyrosine kinase signaling specificity and cell fate determination. F1000Research 7, pages 872.
Crossref
Ranjeet Kumar, Akriti Gupta Jain, Mamoon Ur Rashid, Saeed Ali, Neelam Khetpal, Ishtiaq Hussain & Sarfraz Ahmad. 2018. Role of Tyrosine Kinases in Gastrointestinal Malignancies. Role of Tyrosine Kinases in Gastrointestinal Malignancies 1 14 .
Deepti Narla, Stacey B Slagle, Caitlin M Schaefer, Daniel S Bushnell, Pawan Puri & Carlton M Bates. (2017) Loss of peri-Wolffian duct stromal Frs2α expression in mice leads to abnormal ureteric bud induction and vesicoureteral reflux. Pediatric Research 82:6, pages 1022-1029.
Crossref
Michael Ebeid & Sung-Ho Huh. (2017) FGF signaling: diverse roles during cochlear development. BMB Reports 50:10, pages 487-495.
Crossref
Chi-Hwa Yang, Yu-Jung Yeh, Jiz-Yuh Wang, Ya-Wen Liu, Yen-Lin Chen, Hui-Wen Cheng, Chun-Mei Cheng, Yung-Jen Chuang, Chiou-Hwa Yuh & Yi-Rong Chen. (2017) NEAP/DUSP26 suppresses receptor tyrosine kinases and regulates neuronal development in zebrafish. Scientific Reports 7:1.
Crossref
Kunbin Ke, Hongjian Li, Hong Yao, Xi-Nan Shi, Chao Dong, Ying Zhu, Xu Liu, Ling Li, Kwong-Sak Leung, Man-Hon Wong, Xiao-Dong Liu, Hsiang-fu Kung & Marie Chia-mi Lin. (2017) In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma. Chemical Biology & Drug Design 89:4, pages 505-513.
Crossref
Xiaomian Lin, Li Song, Dan He, Xiangfeng Zeng, Jianzhang Wu, Wu Luo, Qi Yang, Jizhong Wang, Tianxiang Wang, Jialong Cai, Yanling Lin, Fubin Lai, Wentao Peng & Xiaoping Wu. (2017) An FGF8b-mimicking peptide with potent antiangiogenic activity. Molecular Medicine Reports 16:1, pages 894-900.
Crossref
Barbara Haenzi & Lawrence D. F. Moon. (2017) The Function of FGFR1 Signalling in the Spinal Cord: Therapeutic Approaches Using FGFR1 Ligands after Spinal Cord Injury. Neural Plasticity 2017, pages 1-13.
Crossref
Pei-Yu Chen, Lingfeng Qin, Guangxin Li, George Tellides & Michael Simons. (2016) Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGFβ)-dependent smooth muscle cell phenotype modulation. Scientific Reports 6:1.
Crossref
Lina Korsensky & Dina Ron. (2016) Regulation of FGF signaling: Recent insights from studying positive and negative modulators. Seminars in Cell & Developmental Biology 53, pages 101-114.
Crossref
J. Richard Brewer, Pierre Mazot & Philippe Soriano. (2016) Genetic insights into the mechanisms of Fgf signaling. Genes & Development 30:7, pages 751-771.
Crossref
Barbara Haenzi, Katharina Gers-Barlag, Halima Akhoundzadeh, Thomas H. Hutson, Sean C. Menezes, Mary Bartlett Bunge & Lawrence D. F. Moon. (2016) Overexpression of the Fibroblast Growth Factor Receptor 1 (FGFR1) in a Model of Spinal Cord Injury in Rats. PLOS ONE 11:3, pages e0150541.
Crossref
Laurent A F Frantz, Joshua G Schraiber, Ole Madsen, Hendrik-Jan Megens, Alex Cagan, Mirte Bosse, Yogesh Paudel, Richard P M A Crooijmans, Greger Larson & Martien A M Groenen. (2015) Evidence of long-term gene flow and selection during domestication from analyses of Eurasian wild and domestic pig genomes. Nature Genetics 47:10, pages 1141-1148.
Crossref
J. Richard Brewer, Andrei Molotkov, Pierre Mazot, Renée V. Hoch & Philippe Soriano. (2015) Fgfr1 regulates development through the combinatorial use of signaling proteins. Genes & Development 29:17, pages 1863-1874.
Crossref
Tao Zhang, Yuanyuan Ding, Hongli An, Liuxin Feng & Sicen Wang. (2015) Screening anti-tumor compounds from Ligusticum wallichii using cell membrane chromatography combined with high-performance liquid chromatography and mass spectrometry . Journal of Separation Science 38:18, pages 3247-3253.
Crossref
Zamal Ahmed, Zahra Timsah, Kin M. Suen, Nathan P. Cook, Gilbert R. LeeIVIV, Chi-Chuan Lin, Mihai Gagea, Angel A. Marti & John E. Ladbury. (2015) Grb2 monomer–dimer equilibrium determines normal versus oncogenic function. Nature Communications 6:1.
Crossref
Michel G. Tremblay, Chelsea Herdman, François Guillou, Prakash K. Mishra, Joëlle Baril, Sabrina Bellenfant & Tom Moss. (2015) Extended Synaptotagmin Interaction with the Fibroblast Growth Factor Receptor Depends on Receptor Conformation, Not Catalytic Activity. Journal of Biological Chemistry 290:26, pages 16142-16156.
Crossref
Xuehui Yang, Lucy Liaw, Igor Prudovsky, Peter C. Brooks, Calvin Vary, Leif Oxburgh & Robert Friesel. (2015) Fibroblast Growth Factor Signaling in the Vasculature. Current Atherosclerosis Reports 17:6.
Crossref
David M. Ornitz & Nobuyuki Itoh. (2015) The Fibroblast Growth Factor signaling pathway. WIREs Developmental Biology 4:3, pages 215-266.
Crossref
Valeria Di Giovanni, Kenneth A. Walker, Daniel Bushnell, Caitlin Schaefer, Sunder Sims-Lucas, Pawan Puri & Carlton M. Bates. (2015) Fibroblast growth factor receptor–Frs2α signaling is critical for nephron progenitors. Developmental Biology 400:1, pages 82-93.
Crossref
Li Zhou, Asghar Talebian & Susan O. Meakin. (2014) The Signaling Adapter, FRS2, Facilitates Neuronal Branching in Primary Cortical Neurons via Both Grb2- and Shp2-Dependent Mechanisms. Journal of Molecular Neuroscience 55:3, pages 663-677.
Crossref
Yeon-Jin Kim, Minjin Bahn, Yong Hwan Kim, Jee-Yoon Shin, Seon-Woo Cheong, Bong-Gun Ju, Won-Sun Kim & Chang-Yeol Yeo. (2015) Xenopus laevis FGF receptor substrate 3 (XFrs3) is important for eye development and mediates Pax6 expression in lens placode through its Shp2-binding sites. Developmental Biology 397:1, pages 129-139.
Crossref
Abbie E. Fearon, Athina-Myrto Chioni & Richard P. Grose. 2015. Receptor Tyrosine Kinases: Family and Subfamilies. Receptor Tyrosine Kinases: Family and Subfamilies 265 295 .
Michael Grusch, Karin Schelch, Robert Riedler, Eva Reichhart, Christopher Differ, Walter Berger, Álvaro Inglés‐Prieto & Harald Janovjak. (2014) Spatio‐temporally precise activation of engineered receptor tyrosine kinases by light. The EMBO Journal 33:15, pages 1713-1726.
Crossref
Hong Lu, Ya-Juan Han, Jia-Dong Xu, Wen-Min Xing & Jie Chen. (2014) Proteomic Characterization of Acyclovir-Induced Nephrotoxicity in a Mouse Model. PLoS ONE 9:7, pages e103185.
Crossref
Lei Zeng, Miklos Kuti, Shiraz Mujtaba & Ming-Ming Zhou. (2014) Structural insights into FRS2α PTB domain recognition by neurotrophin receptor TrkB. Proteins: Structure, Function, and Bioinformatics 82:7, pages 1534-1541.
Crossref
Rachel T. Uren & Ann M. Turnley. (2014) Regulation of neurotrophin receptor (Trk) signaling: suppressor of cytokine signaling 2 (SOCS2) is a new player. Frontiers in Molecular Neuroscience 7.
Crossref
Pei-Yu Chen, Lingfeng QinZhen W. Zhuang, George TellidesIrit Lax, Joseph Schlessinger & Michael Simons. (2014) The docking protein FRS2α is a critical regulator of VEGF receptors signaling. Proceedings of the National Academy of Sciences 111:15, pages 5514-5519.
Crossref
Gehad Youssef, Cheryl Gillett, Orunsola Agbaje, Tessa Crompton & Ximena Montano. (2014) Phosphorylation of NTRK1 at Y674/Y675 induced by TP53-dependent repression of PTPN6 expression: A potential novel prognostic marker for breast cancer. Modern Pathology 27:3, pages 361-374.
Crossref
Antje Banning, Nina Kurrle, Melanie Meister & Ritva Tikkanen. (2014) Flotillins in Receptor Tyrosine Kinase Signaling and Cancer. Cells 3:1, pages 129-149.
Crossref
R C Turkington, D B Longley, W L Allen, L Stevenson, K McLaughlin, P D Dunne, J K Blayney, M Salto-Tellez, S Van Schaeybroeck & P G Johnston. (2014) Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer. Cell Death & Disease 5:2, pages e1046-e1046.
Crossref
Lisa Salazar, Tamara Kashiwada, Pavel Krejci, April N. Meyer, Malcolm Casale, Matthew Hallowell, William R. Wilcox, Daniel J. Donoghue & Leslie Michels Thompson. (2014) Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFβ-Activated Kinase 1 Tyrosine Phosphorylation and NFκB Signaling in Multiple Myeloma and Bladder Cancer. PLoS ONE 9:1, pages e86470.
Crossref
F. C. Kelleher, H. O'Sullivan, E. Smyth, R. McDermott & A. Viterbo. (2013) Fibroblast growth factor receptors, developmental corruption and malignant disease. Carcinogenesis 34:10, pages 2198-2205.
Crossref
Jose Teixeira & Antonio VicenteBas Brinkhof, Bernard Roelen & Henk Haagsman. 2013. Engineering Aspects of Food Biotechnology. Engineering Aspects of Food Biotechnology 111 142 .
John HinesJonathan D. GoughTimothy W. CorsonCraig M. Crews. (2013) Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs. Proceedings of the National Academy of Sciences 110:22, pages 8942-8947.
Crossref
Melanie Meister, Ana Tomasovic, Antje Banning & Ritva Tikkanen. (2013) Mitogen-Activated Protein (MAP) Kinase Scaffolding Proteins: A Recount. International Journal of Molecular Sciences 14:3, pages 4854-4884.
Crossref
Ci-Di Chen, Jacob A. Sloane, Hu Li, Nurgul Aytan, Eustathia L. Giannaris, Ella Zeldich, Jason D. Hinman, Alpaslan Dedeoglu, Douglas L. Rosene, Rashmi Bansal, Jennifer I. Luebke, Makoto Kuro-o & Carmela R. Abraham. (2013) The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS. The Journal of Neuroscience 33:5, pages 1927-1939.
Crossref
Hongge Li, Chenqi Tao, Zhigang Cai, Kristina Hertzler-Schaefer, Tamica N. Collins, Fen Wang, Gen-Sheng Feng, Noriko Gotoh & Xin Zhang. (2013) Frs2α and Shp2 signal independently of Gab to mediate FGF signaling in lens development. Journal of Cell Science.
Crossref
R.A. Bradshaw, R.J. Chalkley, J. Biarc & A.L. Burlingame. (2013) Receptor tyrosine kinase signaling mechanisms: Devolving TrkA responses with phosphoproteomics. Advances in Biological Regulation 53:1, pages 87-96.
Crossref
Regina Irschick, Tobias Trost, Georg Karp, Barbara Hausott, Maria Auer, Peter Claus & Lars Klimaschewski. (2012) Sorting of the FGF receptor 1 in a human glioma cell line. Histochemistry and Cell Biology 139:1, pages 135-148.
Crossref
Bhavani P. MadakashiraDaniel A. KobrinskiAndrew D. HancherElizabeth C. ArnemanBrad D. WagnerFen WangHailey ShinFrank J. LovicuLixing W. RenekerMichael L. Robinson. (2012) Frs2α enhances fibroblast growth factor-mediated survival and differentiation in lens development. Development 139:24, pages 4601-4612.
Crossref
Shinichiro Oku, Talitha van der Meulen, Jeremy Copp, Gary Glenn & Peter van der Geer. (2012) Engineering NGF receptors to bind Grb2 directly uncovers differences in signaling ability between Grb2- and ShcA-binding sites. FEBS Letters 586:20, pages 3658-3664.
Crossref
Xiaofeng Ding, Zijian Yang, Fangliang Zhou, Xiang Hu, Chang Zhou, Chang Luo, Zhicheng He, Qian Liu, Hong Li, Feng Yan, Fangmei Wang, Shuanglin Xiang & Jian Zhang. (2012) Human Intersectin 2 (ITSN2) binds to Eps8 protein and enhances its degradation. BMB Reports 45:3, pages 183-188.
Crossref
Li Zou, Sheng Cao, Ningling Kang, Robert C. Huebert & Vijay H. Shah. (2012) Fibronectin Induces Endothelial Cell Migration through β1 Integrin and Src-dependent Phosphorylation of Fibroblast Growth Factor Receptor-1 at Tyrosines 653/654 and 766. Journal of Biological Chemistry 287:10, pages 7190-7202.
Crossref
Ana Tomasovic, Stephanie Traub & Ritva Tikkanen. (2012) Molecular Networks in FGF Signaling: Flotillin-1 and Cbl-Associated Protein Compete for the Binding to Fibroblast Growth Factor Receptor Substrate 2. PLoS ONE 7:1, pages e29739.
Crossref
Li Qin, Jennifer L. Bromberg-White & Chao-Nan Qian. 2012. 191 239 .
John F. Kuemmerle, John A. Barnard & Kirk M. McHugh. 2012. Physiology of the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract 199 277 .
Andrew Beenken & Moosa Mohammadi. 2012. Endocrine FGFs and Klothos. Endocrine FGFs and Klothos 1 24 .
Mingqiang Ren, Haiyan Qin, Ruizhe Ren, Josephine Tidwell & John K. Cowell. (2011) Src Activation Plays an Important Key Role in Lymphomagenesis Induced by FGFR1 Fusion Kinases. Cancer Research 71:23, pages 7312-7322.
Crossref
Genshi Zhao, Wei-ying Li, Daohong Chen, James R. Henry, Hong-Yu Li, Zhaogen Chen, Mohammad Zia-Ebrahimi, Laura Bloem, Yan Zhai, Karen Huss, Sheng-bin Peng & Denis J. McCann. (2011) A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models. Molecular Cancer Therapeutics 10:11, pages 2200-2210.
Crossref
Vito Guagnano, Pascal Furet, Carsten Spanka, Vincent Bordas, Mickaël Le Douget, Christelle Stamm, Josef Brueggen, Michael R. Jensen, Christian Schnell, Herbert Schmid, Markus Wartmann, Joerg Berghausen, Peter Drueckes, Alfred Zimmerlin, Dirksen Bussiere, Jeremy Murray & Diana Graus Porta. (2011) Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase. Journal of Medicinal Chemistry 54:20, pages 7066-7083.
Crossref
Claudia M. Garcia, Jie Huang, Bhavani P. Madakashira, Ying Liu, Ramya Rajagopal, Lisa Dattilo, Michael L. Robinson & David C. Beebe. (2011) The function of FGF signaling in the lens placode. Developmental Biology 351:1, pages 176-185.
Crossref
Hongyan Zhu, Laurence Duchesne, Philip S Rudland & David G Fernig. (2010) The heparan sulfate co-receptor and the concentration of fibroblast growth factor-2 independently elicit different signalling patterns from the fibroblast growth factor receptor. Cell Communication and Signaling 8:1.
Crossref
Tilman Brummer, Carsten Schmitz-Peiffer & Roger J. Daly. (2010) Docking proteins. FEBS Journal 277:21, pages 4356-4369.
Crossref
Steve Jean, Alexander Mikryukov, Michel G. Tremblay, Joëlle Baril, François Guillou, Sabrina Bellenfant & Tom Moss. (2010) Extended-Synaptotagmin-2 Mediates FGF Receptor Endocytosis and ERK Activation In Vivo. Developmental Cell 19:3, pages 426-439.
Crossref
Chan-Young Jeon, Hee-Jun Kim, Hiroshi Morii, Nozomu Mori, Jeffrey Settleman, Jae-Yong Lee, Jaebong Kim, Sung-Chan Kim & Jae-Bong Park. (2010) Neurite outgrowth from PC12 cells by basic fibroblast growth factor (bFGF) is mediated by RhoA inactivation through p190RhoGAP and ARAP3. Journal of Cellular Physiology 224:3, pages 786-794.
Crossref
Te-Wen Lo, Daniel C Bennett, S Jay Goodman & Michael J Stern. (2010) Caenorhabditis elegans Fibroblast Growth Factor Receptor Signaling Can Occur Independently of the Multi-Substrate Adaptor FRS2 . Genetics 185:2, pages 537-547.
Crossref
Seizo Koshiba, Hua Li, Yoko Motoda, Tadashi Tomizawa, Takuma Kasai, Naoya Tochio, Takashi Yabuki, Takushi Harada, Satoru Watanabe, Akiko Tanaka, Mikako Shirouzu, Takanori Kigawa, Tadashi Yamamoto & Shigeyuki Yokoyama. (2010) Structural basis for the recognition of nucleophosmin-anaplastic lymphoma kinase oncoprotein by the phosphotyrosine binding domain of Suc1-associated neurotrophic factor-induced tyrosine-phosphorylated target-2. Journal of Structural and Functional Genomics 11:2, pages 125-141.
Crossref
Mary Elizabeth Pownall & Harry V. Isaacs. (2010) FGF Signalling in Vertebrate Development. Colloquium Series on Developmental Biology 1:1, pages 1-75.
Crossref
Yi Pan, Christian Carbe, Andrea Powers, Gen-Sheng Feng & Xin Zhang. (2010) Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development. Development 137:7, pages 1085-1093.
Crossref
Chan-Young JeonHee-Jun KimJae-Yong LeeJaebong KimSung-Chan KimJae-Bong Park. (2010) p190RhoGAP and Rap-dependent RhoGAP (ARAP3) inactivate RhoA in response to nerve growth factor leading to neurite outgrowth from PC12 cells. Experimental and Molecular Medicine 42:5, pages 335.
Crossref
Victoria Knights & Simon J. Cook. (2010) De-regulated FGF receptors as therapeutic targets in cancer. Pharmacology & Therapeutics 125:1, pages 105-117.
Crossref
Zamal Ahmed, Roger George, Chi-Chuan Lin, Kin Man Suen, James A. Levitt, Klaus Suhling & John E. Ladbury. (2010) Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function. Cellular Signalling 22:1, pages 23-33.
Crossref
Kristine A. Drafahl, Christopher W. McAndrew & Daniel J. Donoghue. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling 1939 1947 .
Dengke K Ma, Karthikeyan Ponnusamy, Mi-Ryoung Song, Guo-li Ming & Hongjun Song. (2009) Molecular genetic analysis of FGFR1 signalling reveals distinct roles of MAPK and PLCγ1 activation for self-renewal of adult neural stem cells. Molecular Brain 2:1.
Crossref
Sunder Sims-LucasLuise Cullen-McEwenVeraragavan P. EswarakumarDavid HainsKayle KishBrian BecknellJue ZhangJohn F. BertramFen WangCarlton M. Bates. (2009) Deletion of Frs2α from the ureteric epithelium causes renal hypoplasia. American Journal of Physiology-Renal Physiology 297:5, pages F1208-F1219.
Crossref
Faraz K. Mardakheh, Mona Yekezare, Laura M. Machesky & John K. Heath. (2009) Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signaling. Journal of Cell Biology 187:2, pages 265-277.
Crossref
Amelie Stein, Roland A. Pache, Pau Bernadó, Miquel Pons & Patrick Aloy. (2009) Dynamic interactions of proteins in complex networks: a more structured view. FEBS Journal 276:19, pages 5390-5405.
Crossref
Wenchao Zhou, Xiujing Feng, Yingjie Wu, Johannes Benge, Zhe Zhang & Zhengjun Chen. (2009) FGF-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the FGF pathway. Cell Research 19:10, pages 1165-1177.
Crossref
Olena GorbenkoGalyna OvcharenkoTetyana KlymenkoOlexandr ZhyvoloupNadia GamanDarija VolkovaIvan GoutValeriy Filonenko. (2009) Generation of Monoclonal Antibody Targeting Fibroblast Growth Factor Receptor 3. Hybridoma 28:4, pages 295-300.
Crossref
Bodo C. Melnik, Gerd Schmitz & Christos C. Zouboulis. (2009) Anti-Acne Agents Attenuate FGFR2 Signal Transduction in Acne. Journal of Investigative Dermatology 129:8, pages 1868-1877.
Crossref
Lu ZhiminHunter Tony. (2009) Degradation of Activated Protein Kinases by Ubiquitination. Annual Review of Biochemistry 78:1, pages 435-475.
Crossref
L. Salazar, T. Kashiwada, P. Krejci, P. Muchowski, D. Donoghue, W. R. Wilcox & L. M. Thompson. (2009) A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells. Human Molecular Genetics 18:11, pages 1951-1961.
Crossref
Pei-Yu Chen, Michael Simons & Robert Friesel. (2009) FRS2 via Fibroblast Growth Factor Receptor 1 Is Required for Platelet-derived Growth Factor Receptor β-mediated Regulation of Vascular Smooth Muscle Marker Gene Expression. Journal of Biological Chemistry 284:23, pages 15980-15992.
Crossref
Jiyoung Y. Cha, Savitri Maddileti, Natalia Mitin, T.Kendall Harden & Channing J. Der. (2009) Aberrant Receptor Internalization and Enhanced FRS2-dependent Signaling Contribute to the Transforming Activity of the Fibroblast Growth Factor Receptor 2 IIIb C3 Isoform. Journal of Biological Chemistry 284:10, pages 6227-6240.
Crossref
Yuriko Minegishi, Hiroko Iwanari, Yasuhiro Mochizuki, Takako Horii, Tomoko Hoshino, Tatsuhiko Kodama, Takao Hamakubo & Noriko Gotoh. (2009) Prominent expression of FRS2β protein in neural cells and its association with intracellular vesicles. FEBS Letters 583:4, pages 807-814.
Crossref
Jue ZhangYongshun LinYongyou ZhangYongsheng LanChunhong LinAnne M. MoonRobert J. SchwartzJames F. MartinFen Wang. (2008) Frs2 α-deficiency in cardiac progenitors disrupts a subset of FGF signals required for outflow tract morphogenesis . Development 135:21, pages 3611-3622.
Crossref
Junya Fukai, Hideyuki Yokote, Ryuya Yamanaka, Tokuzo Arao, Kazuto Nishio & Toru Itakura. (2008) EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line. Molecular Cancer Therapeutics 7:9, pages 2768-2778.
Crossref
Noriko Gotoh. (2008) Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Science 99:7, pages 1319-1325.
Crossref
Zamal AhmedAnnika C. SchüllerKlaus SuhlingCarolyn TregidgoJohn E. Ladbury. (2008) Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling. Biochemical Journal 413:1, pages 37-49.
Crossref
Leanne M. Cotton, Moira K. O’Bryan & Barry T. Hinton. (2008) Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction. Endocrine Reviews 29:2, pages 193-216.
Crossref
Ben Margolis & Linton M. Traub. 2008. Protein Science Encyclopedia. Protein Science Encyclopedia.
Yongyou ZhangJue ZhangYongshun LinYongsheng LanChunhong LinJim W. XuanMichael M. ShenWallace L. McKeehanNorman M. GreenbergFen Wang. (2008) Role of epithelial cell fibroblast growth factor receptor substrate 2α in prostate development, regeneration and tumorigenesis. Development 135:4, pages 775-784.
Crossref
S.-H. Kim, Y. Hu, S. Cadman & P. Bouloux. (2007) Diversity in Fibroblast Growth Factor Receptor 1 Regulation: Learning from the Investigation of Kallmann Syndrome. Journal of Neuroendocrinology 20:2, pages 141-163.
Crossref
Yongyou Zhang, Kerstin McKeehan, Yongshun Lin, Jue Zhang & Fen Wang. (2008) Fibroblast Growth Factor Receptor 1 (FGFR1) Tyrosine Phosphorylation Regulates Binding of FGFR Substrate 2α (FRS2α) But Not FRS2β to the Receptor. Molecular Endocrinology 22:1, pages 167-175.
Crossref
Ynuk Bossé & Marek Rola-Pleszczynski. (2008) FGF2 in asthmatic airway-smooth-muscle-cell hyperplasia. Trends in Molecular Medicine 14:1, pages 3-11.
Crossref
Marco Presta, Stefania Mitola, Patrizia Dell'Era, Daria Leali, Stefania Nicoli, Emanuela Moroni & Marco Rusnati. 2008. Angiogenesis. Angiogenesis 77 88 .
Anna Vecchione, Helen J. Cooper, Kimberley J. Trim, Shiva Akbarzadeh, John K. Heath & Lee M. Wheldon. (2007) Protein partners in the life history of activated fibroblast growth factor receptors. PROTEOMICS 7:24, pages 4565-4578.
Crossref
Hesham M. AminRaymond Lai. (2007) Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood 110:7, pages 2259-2267.
Crossref
Lavinia Vittoria Lotti, Sabrina Rotolo, Federica Francescangeli, Luigi Frati, Maria Rosaria Torrisi & Cinzia Marchese. (2007) AKT and MAPK signaling in KGF-treated and UVB-exposed human epidermal cells. Journal of Cellular Physiology 212:3, pages 633-642.
Crossref
V. P. Chekhonin, I. I. Shepeleva & O. I. Gurina. (2007) Signal functions of NCAM. Neurochemical Journal 1:2, pages 113-126.
Crossref
M Chikamori, J Fujimoto, N Tokai-Nishizumi & T Yamamoto. (2006) Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformation. Oncogene 26:20, pages 2950-2954.
Crossref
Jae Cheal Yoo & Michael J. Hayman. (2007) Annexin II binds to SHP2 and this interaction is regulated by HSP70 levels. Biochemical and Biophysical Research Communications 356:4, pages 906-911.
Crossref
Yosuke Matsubara, Ichiro Kawasaki, Seiichi Urushiyama, Tomoharu Yasuda, Masaki Shirakata, Yuichi Iino, Hiroshi Shibuya & Yuji Yamanashi. (2007) The adaptor-like protein ROG-1 is required for activation of the Ras-MAP kinase pathway and meiotic cell cycle progression in Caenorhabditis elegans. Genes to Cells 12:3, pages 407-420.
Crossref
Joffrey Degoutin, Marc Vigny & Jean Y. Gouzi. (2007) ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation. FEBS Letters 581:4, pages 727-734.
Crossref
Adam W. Avery, Claudia Figueroa & Anne B. Vojtek. (2007) UNC-51-like kinase regulation of fibroblast growth factor receptor substrate 2/3. Cellular Signalling 19:1, pages 177-184.
Crossref
V. P. Eswarakumar, F. Özcan, E. D. Lew, J. H. Bae, F. Tomé, C. J. Booth, D. J. Adams, I. Lax & J. Schlessinger. (2006) Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proceedings of the National Academy of Sciences 103:49, pages 18603-18608.
Crossref
Amy L. Donner, Salil A. Lachke & Richard L. Maas. (2006) Lens induction in vertebrates: Variations on a conserved theme of signaling events. Seminars in Cell & Developmental Biology 17:6, pages 676-685.
Crossref
L Huang, M Watanabe, M Chikamori, Y Kido, T Yamamoto, M Shibuya, N Gotoh & N Tsuchida. (2006) Unique role of SNT-2/FRS2β/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways. Oncogene 25:49, pages 6457-6466.
Crossref
T. Kalle Lundgren, Rizaldy P. Scott, Matthew Smith, Tony Pawson & Patrik Ernfors. (2006) Engineering the Recruitment of Phosphotyrosine Binding Domain-containing Adaptor Proteins Reveals Distinct Roles for RET Receptor-mediated Cell Survival. Journal of Biological Chemistry 281:40, pages 29886-29896.
Crossref
M Manuvakhova, J V Thottassery, S Hays, Z Qu, S S Rentz, L Westbrook & F G Kern. (2006) Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells. Oncogene 25:44, pages 6003-6014.
Crossref
David Berry, David M. Lynn, Eric Berry, Ram Sasisekharan & Robert Langer. (2006) Heparin localization and fine structure regulate Burkitt’s lymphoma growth. Biochemical and Biophysical Research Communications 348:3, pages 850-856.
Crossref
Atsuki Fukushima, Yasue Hatanaka, Jing-Wen Chang, Masako Takamatsu, Nagendra Singh & Makio Iwashima. (2006) Lck couples Shc to TCR signaling. Cellular Signalling 18:8, pages 1182-1189.
Crossref
John B. Easton, Amanda R. Royer & David S. Middlemas. (2006) The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor. Journal of Neurochemistry 97:3, pages 834-845.
Crossref
Star M. Dunham-Ems, Haridas E. Pudavar, Jason M. Myers, Pamela A. Maher, Paras N. Prasad & Michal K. Stachowiak. (2006) Factors Controlling Fibroblast Growth Factor Receptor-1's Cytoplasmic Trafficking and Its Regulation as Revealed by FRAP Analysis. Molecular Biology of the Cell 17:5, pages 2223-2235.
Crossref
Ágnes Csiszár. (2006) Structural and functional diversity of adaptor proteins involved in tyrosine kinase signalling. BioEssays 28:5, pages 465-479.
Crossref
Scott J. Dixon, James I.S. MacDonald, Kim N. Robinson, Christopher J. Kubu & Susan O. Meakin. (2006) Trk receptor binding and neurotrophin/fibroblast growth factor (FGF)-dependent activation of the FGF receptor substrate (FRS)-3. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1763:4, pages 366-380.
Crossref
Twila A. Jackson, David M. Koterwas & Andrew P. Bradford. (2006) Differential regulation of cell growth and gene expression by FGF-2 and FGF-4 in pituitary lactotroph GH4 cells. Molecular and Cellular Endocrinology 247:1-2, pages 183-191.
Crossref
Renée V. HochPhilippe Soriano. (2006) Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development. Development 133:4, pages 663-673.
Crossref
John A. Barnard & Kirk M. McHugh. 2006. Physiology of the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract 183 246 .
K. Unsicker, B. Reuss & O. von Bohlen und Halbach. 2006. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology 93 121 .
Jean Y. Gouzi, Christel Moog-Lutz, Marc Vigny & Nicole Brunet-de Carvalho. (2005) Role of the subcellular localization of ALK tyrosine kinase domain in neuronal differentiation of PC12 cells. Journal of Cell Science 118:24, pages 5811-5823.
Crossref
Linda J. Pike. (2005) Growth factor receptors, lipid rafts and caveolae: An evolving story. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1746:3, pages 260-273.
Crossref
Denise Tefft, Stijn P. De Langhe, Pierre-Marie Del Moral, Frederic Sala, Wei Shi, Saverio Bellusci & David Warburton. (2005) A novel function for the protein tyrosine phosphatase Shp2 during lung branching morphogenesis. Developmental Biology 282:2, pages 422-431.
Crossref
Peng Huang & Michael J. Stern. (2005) FGF signaling in flies and worms: More and more relevant to vertebrate biology. Cytokine & Growth Factor Reviews 16:2, pages 151-158.
Crossref
V.P. Eswarakumar, I. Lax & J. Schlessinger. (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine & Growth Factor Reviews 16:2, pages 139-149.
Crossref
Tomoya MaedaFumiharu YagasakiMaho IshikawaNaoki TakahashiMasami Bessho. (2005) Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML. Blood 105:5, pages 2115-2123.
Crossref
Ralph T. Böttcher & Christof Niehrs. (2005) Fibroblast Growth Factor Signaling during Early Vertebrate Development. Endocrine Reviews 26:1, pages 63-77.
Crossref
Mara Ceridono, Francesca Belleudi, Simona Ceccarelli & Maria Rosaria Torrisi. (2005) Tyrosine 769 of the keratinocyte growth factor receptor is required for receptor signaling but not endocytosis. Biochemical and Biophysical Research Communications 327:2, pages 523-532.
Crossref
Mark T. Uhlik, Brenda Temple, Sompop Bencharit, Adam J. Kimple, David P. Siderovski & Gary L. Johnson. (2005) Structural and Evolutionary Division of Phosphotyrosine Binding (PTB) Domains. Journal of Molecular Biology 345:1, pages 1-20.
Crossref
John E. Ladbury. 2005. Proteomics and Protein-Protein Interactions. Proteomics and Protein-Protein Interactions 165 184 .
N. Gotoh, M. Ito, S. Yamamoto, I. Yoshino, N. Song, Y. Wang, I. Lax, J. Schlessinger, M. Shibuya & R. A. Lang. (2004) Tyrosine phosphorylation sites on FRS2α responsible for Shp2 recruitment are critical for induction of lens and retina. Proceedings of the National Academy of Sciences 101:49, pages 17144-17149.
Crossref
Xuan Li, Valerie G. Brunton, Helen R. Burgar, Lee M. Wheldon & John K. Heath. (2004) FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity. Journal of Cell Science 117:25, pages 6007-6017.
Crossref
Yongyou Zhang, Yongshun Lin, Courtney Bowles & Fen Wang. (2004) Direct Cell Cycle Regulation by the Fibroblast Growth Factor Receptor (FGFR) Kinase through Phosphorylation-dependent Release of Cks1 from FGFR Substrate 2. Journal of Biological Chemistry 279:53, pages 55348-55354.
Crossref
Anders M. Hinsby, Jesper V. Olsen & Matthias Mann. (2004) Tyrosine Phosphoproteomics of Fibroblast Growth Factor Signaling. Journal of Biological Chemistry 279:45, pages 46438-46447.
Crossref
Lin Huang, Noriko Gotoh, Shengliang Zhang, Masabumi Shibuya, Tadashi Yamamoto & Nobuo Tsuchida. (2004) SNT-2 interacts with ERK2 and negatively regulates ERK2 signaling in response to EGF stimulation. Biochemical and Biophysical Research Communications 324:3, pages 1011-1017.
Crossref
Yong Zhang, Zhiyong Yan, Amjad Farooq, Xiujie Liu, Changlin Lu, Ming-Ming Zhou & Cheng He. (2004) Molecular Basis of Distinct Interactions Between Dok1 PTB Domain and Tyrosine-phosphorylated EGF Receptor. Journal of Molecular Biology 343:4, pages 1147-1155.
Crossref
April N. Meyer, Randy F. Gastwirt, David D. Schlaepfer & Daniel J. Donoghue. (2004) The Cytoplasmic Tyrosine Kinase Pyk2 as a Novel Effector of Fibroblast Growth Factor Receptor 3 Activation. Journal of Biological Chemistry 279:27, pages 28450-28457.
Crossref
Yafang Hu, Xiaohong Fang, Star M. Dunham, Claudia Prada, Ewa K. Stachowiak & Michal K. Stachowiak. (2004) 90-kDa Ribosomal S6 Kinase Is a Direct Target for the Nuclear Fibroblast Growth Factor Receptor 1 (FGFR1). Journal of Biological Chemistry 279:28, pages 29325-29335.
Crossref
Magdalena Koziczak, Thomas Holbro & Nancy E Hynes. (2004) Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins. Oncogene 23:20, pages 3501-3508.
Crossref
Noriko Gotoh, Shaked Laks, Misako Nakashima, Irit Lax & Joseph Schlessinger. (2004) FRS2 family docking proteins with overlapping roles in activation of MAP kinase have distinct spatial-temporal patterns of expression of their transcripts. FEBS Letters 564:1-2, pages 14-18.
Crossref
Vigdis Sørensen, Andreas Brech, Denis Khnykin, Elona Kolpakova, Lucia Citores & Sjur Olsnes. (2004) Deletion mutant of FGFR4 induces onion-like membrane structures in the nucleus. Journal of Cell Science 117:9, pages 1807-1819.
Crossref
Arda Bedirian, Cindy Baldwin, Jun-ichi Abe, Tomoko Takano & Serge Lemay. (2004) Pleckstrin Homology and Phosphotyrosine-binding Domain-dependent Membrane Association and Tyrosine Phosphorylation of Dok-4, an Inhibitory Adapter Molecule Expressed in Epithelial Cells. Journal of Biological Chemistry 279:18, pages 19335-19349.
Crossref
James I.S. MacDonald, Chris J. Kubu & Susan O. Meakin. (2004) Nesca, a novel adapter, translocates to the nuclear envelope and regulates neurotrophin-induced neurite outgrowth. Journal of Cell Biology 164:6, pages 851-862.
Crossref
Sergei Roumiantsev, Daniela S Krause, Carola A Neumann, Christopher A Dimitri, Frances Asiedu, Nicholas C.P Cross & Richard A Van Etten. (2004) Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell 5:3, pages 287-298.
Crossref
Chan-Wook Woo, Enrico Lucarelli & Carol J Thiele. (2003) NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number. Oncogene 23:8, pages 1522-1530.
Crossref
Satoshi Yamada, Takaharu Taketomi & Akihiko Yoshimura. (2004) Model analysis of difference between EGF pathway and FGF pathway. Biochemical and Biophysical Research Communications 314:4, pages 1113-1120.
Crossref
Angela Raucci, Emmanuel Laplantine, Alka Mansukhani & Claudio Basilico. (2004) Activation of the ERK1/2 and p38 Mitogen-activated Protein Kinase Pathways Mediates Fibroblast Growth Factor-induced Growth Arrest of Chondrocytes. Journal of Biological Chemistry 279:3, pages 1747-1756.
Crossref
Paul W. Finch & Jeffrey S. Rubin. 2004. 69 136 .
A. Więdłocha & V. Sørensen. 2004. Signalling from Internalized Growth Factor Receptors. Signalling from Internalized Growth Factor Receptors 45 79 .
Fen Wang, Kerstin McKeehan, Chundong Yu, Michael Ittmann & Wallace L. McKeehan. (2004) Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia. The Prostate 58:1, pages 1-12.
Crossref
Yehenew M Agazie, Nieves Movilla, Irene Ischenko & Michael J Hayman. (2003) The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3. Oncogene 22:44, pages 6909-6918.
Crossref
Joseph SchlessingerMark A. Lemmon. (2003) SH2 and PTB Domains in Tyrosine Kinase Signaling. Science's STKE 2003:191.
Crossref
Lars Lundin, Lars Rönnstrand, Michael Cross, Carina Hellberg, Ulf Lindahl & Lena Claesson-Welsh. (2003) Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin. Experimental Cell Research 287:1, pages 190-198.
Crossref

Displaying 200 of 255 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.